CARDIOMETABOLIC TEST


TEST FOR HEART DISEASE

The CardioMetabolic Test offers a clinically relevant evaluation which allows you to see your risk assessments for cardiovascular diseases, your pre-diabetes markers, your lipid profile, and your current vascular inflammation. Additionally, blood levels of omega-3 fatty acids may be more informative than any other cardiovascular disease risk factor, since it is physiologically relevant and easily modified. 

Standard cholesterol testing of LDL (“bad”) and HDL (“good”) cholesterols don’t tell us enough about the particle breakdowns of each of these LDL and HDL families. The advanced LPP Plus test measures lipoprotein size AND density, triglycerides, and cardiovascular risk stratification, on top of traditional cholesterol screening.

 
cholesterol 2.jpg

 
inflammation.jpg

GO BEYOND CHOLESTEROL

Not only that, when it comes to your heart health, cholesterol is not the whole story! Metabolic dysfunction - a chronic, inflammatory state - is often the root cause of weight gain, diabetes, hormone dysfunction, and heart disease. Weight gain, which is often the first noticeable sign of inflammation, reflects the accumulation of excess body fat. Included in the CardioMetabolic test is our OmegaCheck, which measures the ratio of omega-6 to omega-3 fatty acids in one’s blood. The higher the content of omega-3 fatty acids, the lower the risk of a fatal heart attack and other inflammatory conditions.


SEE THE WHOLE PICTURE

In addition, this test includes the Pre-Diabetes Biomarkers to help identify metabolic abnormalities that may progress into diabetes. This is an evaluation of specific risk factors that can indicate the presence of Pre-Diabetes and assesses a person’s risk for developing Type 2 Diabetes.

Collectively, these check points help clients understand that not just one factor, but rather a constellation of factors, contributes to the genesis and progression towards cardiovascular disease.

This test is also a great compliment to our Micronutrient and Telomere tests, and it is recommended that you perform all three to obtain a more complete profile of your body, its function, and its needs going forward, allowing you to be the best version of you.

 
cardiovascular 3.jpg

CARDIOMETABOLIC TEST: $200

**9-12 HOURS OF FASTING REQUIRED FOR OPTIMAL RESULTS**


Lipoprotein Particle Profile (LPP+) 

Advanced technology which accurately measures both the density and number of lipoprotein particles. Measuring the lipoprotein subgroups is the only way to evaluate new risk factors, which is crucial for an accurate assessment of cardiovascular risk – according to the National Cholesterol Education Program (NCEP).

metabolic risk

CARDIOVASCULAR RISK

INFLAMMATION MARKERS

  • Insuline

  • Glucose

  • Hemoglobin A1c

  • C-Peptide

  • Adiponectin

  • Metabolic Syndrome

  • Unique CardioMetabolic Risk Score estimates the risk of developing diabetes and associated conditions

Lipid Panel

  • Total Cholesterol

  • LDL & HDL Cholesterol

  • Triglycerides

  • Non-HD Cholesterol (calc)

Lipoprotein Particle Numbers

  • VLDL Particles

  • Total LDL Particles

  • Non-HDL Particles (RLP, Small, Dense LDL III & IV)

  • Total HDL Particles

  • Large, buoyant HDL 2b

  • ApoB 100

  • Lp(a)

  • C-Reactive Protein-hs

  • Homocysteine


Pre-Diabetes Risk

diabetes.jpg

The Pre-Diabetes Biomarkers identify metabolic abnormalities that may progress into diabetes.  Pre-diabetes is a condition where the body cannot efficiently metabolize foods, especially carbohydrates, resulting in impaired glycemic (blood sugar) control which may progress to diabetes when not properly treated or addressed through lifestyle changes.

The Pre-Diabetes Risk Score is a way to estimate a patient's risk of developing diabetes and associated complications such as heart disease or stroke.  The following tests have the largest impact on the pre-diabetes risk score: hemoglobin A1c, fasting blood sugar and metabolic syndrome traits.  Other factors that significantly affect a pre-diabetic risk but that are not included in this report include weight, blood pressure (hypertension), smoking, inflammation and family history. 

  • Glucose - snapshot of blood sugar at time of blood draw

  • Insulin - correlates to the efficiency with which a person can metabolize carbohydrates; high fasting levels indicate insulin resistance and possible pre-diabetes.

  • Hemoglobin A1C - long term (2-3 months) marker of glycemic control; also considered a marker of accelerated aging

  • C-peptide - a measure of endogenous insulin production; useful in distinguishing between ty pe 1 and type 2 diabetes

  • Adiponectin - a hormone that ezymatically controls metabolism; high levels beneficial and indicate efficient cellular energy production

  • Metabolic syndrome traits - A diagnosis of metabolic syndrome is confirmed if any three of the following six traits exist in a patient: (1) high triglycerides (2) high glucose (3) low HDL (4) high blood pressure (5) high waist circumference or (6) increased small dense LDL

Omega-3 Index

omegas 2.jpg

The CardioMetabolic test also measures the percentage of EPA and DHA levels in red blood cell membranes (RBC's), which are highly correlated to myocardial membrane omega-3 levels.. In addition to determining the risk for Sudden Cardiac Death, there are potential benefits of omega-3 oils in a wide range of medical conditions.

Half of all fatal heart attacks are due to SCD which is defined as death within one hour of the event. Most sudden cardiac deaths are due to cardiac arrhythmia. An adequate level of the omega-3’s EPA and especially DHA can reduce this risk by 90%.

The Omega-3 Index is a great complement to the LPP and Pre-Diabetes Risk tests for cardiovascular risk reduction and the management and treatment of lipoprotein disorders.

When treating triglycerides and/or RLP (remnant lipoprotein) as measured by the LPP test, omega-3’s and especially DHA should be considered due to the added benefit of SCD reduction. In metabolic syndrome patients the omega-3 DHA will not only reduce triglycerides and RLP but will increase the size of LDL and increase HDL 2b as measured with the LPP test

The target Omega-3 Index is 8% and above, a level that current research indicates is associated with the lowest risk* for death from CHD. This is also a typical level in Japan, a country with one of the lowest rates of sudden cardiac death in the world. An Index of 4% or less (which is common in the US) indicates the highest risk. At present, there are no known sex- or age-specific values.

 

WITH YOUR RESULTS, WE CAN ADDRESS DEFICIENCIES WITH A CUSTOM PROGRAM OF INFUSIONS, INJECTABLES, AND SUPPLEMENTS TO PROVIDE YOUR BODY WHAT IT NEEDS TO naturally balance omega levels, reduce triglycerides, raise levels of 'good' cholesterol, reduce levels of 'bad' cholesterol, and fortify your heart